Tags : Global

Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis

Tuba Khan December 31, 2020

Shots: The companies collaborated to evaluate ruxolitinib in combination with CK0804 in patients with MF and plan to initiate a P-Ib study. Incyte will fund the study while operationalized by Cellenkos Cellenkos to receive $20M as licensing fee, ~$294.5M as development, regulatory and commercialization milestones along with royalties on sales of therapies, if approved. Incyte […]Read More

Clinical Trials

Roche Reports Results of Faricimab in Two Global P-III Studies

Tuba Khan December 22, 2020

Shots: The P-III YOSEMITE & RHINE studies assessing faricimab vs aflibercept in 1891 people living with DME. The studies include 3 treatment arms: faricimab (6mg) administered at personalized dosing intervals of ~16wks and at fixed 8wks. intervals & aflibercept (2mg) at fixed 8wks. intervals The studies met its 1EPs i.e faricimab in both the doses […]Read More

Biotech COVID-19

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

Tuba Khan September 24, 2020

Shots: The initiation of the ENSEMBLE trial follows positive interim results of P-I/IIa study demonstrating the safety and immunogenicity of JNJ-78436735 following a single vaccination. The results have been submitted to medRxiv and expected to be published imminently The P-III ENSEMBLE study is designed to assess the safety & efficacy of a single vaccine dose […]Read More

Viewpoints

ViewPoints Article: Covid-19 Impact On Global Telemedicine Market

Vartika Singh September 1, 2020

The concept of telemedicine has evolved in recent years. As people are demanding easier ways to avail of medical treatment and diagnosis, there have been several advances in telemedicine. Telemedicine is a method that involves providing clinical services through a distance. Through telemedicine, the user doesn’t necessarily have to be present at the hospital or […]Read More

Biotech

Roche and UCB Collaborate to Develop UCB0107 for Alzheimer’s Disease

Tuba Khan July 29, 2020

Shots: UCB to receive $120M and is eligible to receive $2B as cost reimbursement, development, and commercial milestones as well as royalties on sales of the therapies, if Roche proceeds the clinical development. Roche to get an exclusive license to develop and commercialize UCB0107 for AD UCB to fund and perform a POC study in […]Read More

Biotech

AstraZeneca Signs an Agreement with Daichii Sankyo to Develop and

Tuba Khan July 27, 2020

Shots: Daichii Sankyo to receive $1B as upfront of which $350M is due upon execution, $325M after 12mos. and $325M after 24 mos., ~$5B as contingent payment including $1B as regulatory milestones, and $4B as commercial milestones, making a total deal value up to ~6B The companies will jointly develop and commercialize DS-1062 globally and […]Read More

COVID-19 M&A

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic

Tuba Khan July 27, 2020

Shots: Sorrento enters into letter of intent to acquire SmartPharm and develops pipeline of gene-encoded therapeutic Ab, initiating with Sorrento’s STI-1499 or COVI-GUARD, currently preclinical studies with an IND submission targeted for Aug’2020. The transaction is expected to be close in Aug’2020. The integration of Sorrento’s G-MAB Ab library and SmartPharm’s GET platform is expected […]Read More

COVID-19 Pharma

Pfizer and BioNTech Provide Updates on its Collaboration for Global

Tuba Khan April 9, 2020

Shots: BioNTech to receive $185M up front, including $72M cash & $113M equity investment, up to $563M as milestone making a total deal value $748M. The companies will equally share the development cost while Pfizer will fund 100% of development cost at the initial level and BioNTech will repay Pfizer its 50% share during the […]Read More

COVID-19 DigiHealth

Medopad Provides its Remote Patient Monitoring Platform to Support Global

Tuba Khan March 27, 2020

Shots: Medopod’s RPM platform will be available for NHS Trusts across the UK as well as global healthcare providers that allow doctors to track patient’s data, symptom progression and flag patients with worsening symptoms, both inside and outside of clinical settings Patients will use the app to share their personal data such as temperature, respiration […]Read More

Biotech

WHO to Accelerate Global Research and Innovation Against Corona Virus

Tuba Khan February 7, 2020

Shots: WHO convoke global research and innovation forum to be held on Feb 11-12, 2020 in Geneva for mobilization of international action in response to the coronavirus (2019-nCoV) and is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness The forum will involve scientist, public health agencies, ministries of health and research […]Read More

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Janssen Signs a Research Agreement with TenNor to Develop Treatments for Nontuberculous Mycobacteria Diseases

Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted Gene Therapy

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Henlius’ HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China

Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19

The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19

Tessa’s CD30 CAR-T Therapy Receives EMA’s PRIME Designation for Relapsed or Refractory Classical Hodgkin Lymphoma

Genmab’s Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA’s Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021

Tags : Global

Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis

Roche Reports Results of Faricimab in Two Global P-III Studies

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

Roche and UCB Collaborate to Develop UCB0107 for Alzheimer’s Disease

AstraZeneca Signs an Agreement with Daichii Sankyo to Develop and

Sorrento to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic

Pfizer and BioNTech Provide Updates on its Collaboration for Global

Medopad Provides its Remote Patient Monitoring Platform to Support Global

WHO to Accelerate Global Research and Innovation Against Corona Virus

Latest Posts

ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

Philips to Acquire Capsule Technologies for ~$635M

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Tags : Global

Latest Posts

Categories

Related Topics